← Leaderboards
A.r.m. Ruhul Amin
Marshall University
$748,010
Attributed
$748,010
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $444K · FY2012–23$500K$375K$250K$125K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$748,010 · 3
By mechanism
R15$444,000 · 1
R03$304,010 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Chemopreventive Agent”
- Norman Wolmark · Nsabp Foundation, Inc.$52,338,276
- Fred M Gordin · Social And Scientific Systems, Inc.$50,695,408
- John Anthony Baron · Dartmouth College$49,812,402
- Caroline C Sigman · Ccs Associates, Inc.$26,419,788
- Jonathan White · Midwest Research Institute$24,635,824
- Thomas W Kensler · Johns Hopkins University$19,150,087
Research focus
Chemopreventive AgentMalignant NeoplasmsPremalignantCancer Cell LineChemopreventionMediatingLesionPathway InteractionsProto-Oncogene Proteins C-AktTissuesSignal TransductionPreventionGrowthEpidermal Growth Factor ReceptorIncidenceIn VivoEgfr InhibitionDesignBaseDrug KineticsHead And Neck Squamous Cell CarcinomaCancer CellChemotherapyCessation Of Life
Grant awards (5)
Targeting oncogenic pathways for chemoprevention of head and neck cancer by FLLL12$444,000
R15 · FY2023 · DE · contact PI
Targeting both intrinsic and extrinsic apoptosis by FLLL-12 in lung cancer$75,660
R03 · FY2014 · CA · contact PI
Targeting both intrinsic and extrinsic apoptosis by FLLL-12 in lung cancer$78,000
R03 · FY2013 · CA · contact PI
Mechanism of chemopreventive synergism from the combination of EGCG and Erlotinib$72,850
R03 · FY2013 · CA · contact PI
Mechanism of chemopreventive synergism from the combination of EGCG and Erlotinib$77,500
R03 · FY2012 · CA · contact PI